Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma-Reference-Cited by-同舟云学术

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma

Published:2002-05-23 Issue:11 Volume:94 Page:2953-2958
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Baur Martina,Kienzer Heinz-Roland,Schweiger Johannes,DeSantis Maria,Gerber Erich,Pont J�rg,Hudec Marcus,Schratter-Sehn Annemarie Ulrike,Wicke Wolfram,Dittrich Christian

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Head and Neck Cancer

2. Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India;F1000Research;2024-07-15

2. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma;Aging;2024-02-26

3. Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India;F1000Research;2023-07-10

4. The role of partial-EMT in the progression of head and neck squamous cell carcinoma;Journal of Oral Biosciences;2022-06

5. How I Treat Advanced Head Neck Cancer;Indian Journal of Medical and Paediatric Oncology;2022-02-12